Significant Associations Between X-ray Repair Cross-Complementing Group 3 Genetic Polymorphisms and Thyroid Cancer Risk.

Xiao-Long Yu,Hu Liu,Bin Wang,Zheng-Ju Fu,Ying Yuan,Sheng-Li Yan,Wen-Juan Zhao,Yan-Gang Wang,Jianming Cai
DOI: https://doi.org/10.1007/s13277-013-1266-1
2013-01-01
Tumor Biology
Abstract:Polymorphisms in X-ray cross-complementing group 3 (XRCC3) are proposed to be associated with cancer susceptibility, but previous studies on the associations between XRCC3 polymorphisms and thyroid cancer are controversial. We performed a systemic review and meta-analysis to investigate the associations of XRCC3 polymorphisms with thyroid cancer risk. We used odds ratio (OR) with 95 % confidence interval (95%CI) to assess the associations. For XRCC3 C241T polymorphism, meta-analysis of total eligible studies showed that there was no association between XRCC3 C241T polymorphism and thyroid cancer risk, but subgroup analysis in Caucasians showed that there was a significant association between XRCC3 C241T polymorphism and thyroid cancer risk (T versus C: OR = 1.30, 95%CI 1.05–1.62, P = 0.01; TT versus CC: OR = 1.74, 95%CI 1.13–2.70, P = 0.01; TT versus CC/CT: OR = 1.74, 95%CI 1.16–2.60, P = 0.007). For XRCC3 A17893G polymorphism, meta-analysis of total eligible studies showed that there was an obvious association between XRCC3 A17893G polymorphism and thyroid cancer risk (GG versus AA/AG: OR = 0.57, 95%CI 0.35–0.93, P = 0.02), but subgroup analysis by ethnicity only identify the significant association in Asians. In summary, the meta-analysis suggests that there are significant associations of XRCC3 polymorphisms with thyroid cancer risk. Besides, more studies with large sample sizes are needed to further assess the associations above.
What problem does this paper attempt to address?